{
    "elements": [
        {
            "type": "image",
            "sequence_num": 1,
            "data": {
                "url": "MSEPO-21088 Management of IntraTHECAL Chemotherapy Policy.001.png"
            }
        },
        {
            "type": "table",
            "sequence_num": 2,
            "data": {
                "num_rows": 16,
                "num_cols": 3,
                "table_items": [
                    {
                        "text": "Document Title:"
                    },
                    {
                        "text": "MANAGEMENT OF INTRATHECAL CHEMOTHERAPY POLICY"
                    },
                    {
                        "text": "Document Reference/Register no:"
                    },
                    {
                        "text": "MSEPO-21088"
                    },
                    {
                        "text": "Version Number:"
                    },
                    {
                        "text": "1.0"
                    },
                    {
                        "text": "Document type: (Policy/ Guideline/ SOP/CCP)"
                    },
                    {
                        "text": "Policy"
                    },
                    {
                        "text": "To be followed by: (Target Staff)"
                    },
                    {
                        "text": "All staff involved in the management of patients receiving Intrathecal Chemotherapy"
                    },
                    {
                        "text": "Ratification Issue Date: (Date document is uploaded onto the intranet)"
                    },
                    {
                        "text": "25 May 2021"
                    },
                    {
                        "text": "Review Date:"
                    },
                    {
                        "text": "24 May 2024"
                    },
                    {
                        "text": "Key word(s) to search for document on intranet:"
                    },
                    {
                        "text": "Intrathecal, IT, chemo, chemotherapy"
                    },
                    {
                        "text": "Developed in response to: (National Guidance/Recommendations (i.e. NICE; RCOG)"
                    },
                    {
                        "text": "HSC 2003/010 & HSC 2008/001 NHS/PSA/RE/2017/004"
                    },
                    {
                        "text": "Contributes to HSC Act 2008 (Regulated Activities) Regulations 2014(Part 3); and CQC Regulations 2009 (Part 4) CQC Fundamental Standards of Quality and Safety:"
                    },
                    {
                        "text": "12"
                    },
                    {
                        "text": "Issuing Division/Directorate:"
                    },
                    {
                        "text": "Division 9 - Pharmacy"
                    },
                    {
                        "text": "Author/Contact: (Asset Administrator)"
                    },
                    {
                        "text": "Simon Worrall"
                    },
                    {
                        "text": "Deputy Chief Pharmacist"
                    },
                    {
                        "text": "Hospital Sites: (tick appropriate box(s) to indicate status of policy review i.e. joint/ independent)"
                    },
                    {
                        "text": "\u2612 MSE NHS Foundation Trust \u2610 Basildon Hospital \u2610 Broomfield Hospital \u2610 Southend Hospital \u2610 Other (please state)"
                    },
                    {
                        "text": "Approval Group / Committee(s):"
                    },
                    {
                        "text": "MSE Medicines Assurance Group Chair action E.Allen in Lieu"
                    },
                    {
                        "text": "21 May 2021"
                    },
                    {
                        "text": "Professionally Approved by: (Asset Owner)"
                    },
                    {
                        "text": "Evelyn Allen"
                    },
                    {
                        "text": "Chief Pharmacist"
                    },
                    {
                        "text": "21 May 2021"
                    },
                    {
                        "text": "Consultation:"
                    },
                    {
                        "text": "(Refer to page 2)"
                    },
                    {
                        "text": "Ratification Group(s):"
                    },
                    {
                        "text": "Joint Document Management Group"
                    },
                    {
                        "text": "25 May 2021"
                    },
                    {
                        "text": "Executive and Clinical Directors (Communication of minutes from Joint Document Management Group)"
                    },
                    {
                        "text": "June 21"
                    },
                    {
                        "text": "Distribution Method:"
                    },
                    {
                        "text": "\u2612 Trust Intranet"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    }
                ]
            }
        },
        {
            "type": "image",
            "sequence_num": 3,
            "data": {
                "url": "MSEPO-21088 Management of IntraTHECAL Chemotherapy Policy.002.png"
            }
        },
        {
            "type": "table",
            "sequence_num": 4,
            "data": {
                "num_rows": 6,
                "num_cols": 2,
                "table_items": [
                    {
                        "text": "Consulted With: (Must include Specialist Pharmacists if the document has any reference to medication)"
                    },
                    {
                        "text": "Date:"
                    },
                    {
                        "text": "Jennie Joyce"
                    },
                    {
                        "text": "Lead Oncology & Haematology Pharmacist - Southend"
                    },
                    {
                        "text": "30 April 2021"
                    },
                    {
                        "text": "Alex Wan"
                    },
                    {
                        "text": "Lead Oncology & Haematology Pharmacist - Basildon"
                    },
                    {
                        "text": "30 April 2021"
                    },
                    {
                        "text": "Evelyn Allen"
                    },
                    {
                        "text": "Intrathecal Lead \u2013 Southend"
                    },
                    {
                        "text": "30 April 2021"
                    },
                    {
                        "text": "Dr Shankari Serumadar"
                    },
                    {
                        "text": "Intrathecal Lead \u2013 Basildon"
                    },
                    {
                        "text": "30 April 2021"
                    },
                    {
                        "text": "Hannah Overland"
                    },
                    {
                        "text": "Deputy Director of Nursing \u2013 Cancer, Palliative Care & End of Life"
                    },
                    {
                        "text": "22 May 2021"
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 5,
            "data": {
                "num_rows": 2,
                "num_cols": 2,
                "table_items": [
                    {
                        "text": "Post/ Approval Committee/ Group: (Must include Medication Assurance Group if the document has any reference to medication)"
                    },
                    {
                        "text": "Date:"
                    },
                    {
                        "text": "Nil"
                    },
                    {
                        "text": ""
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 6,
            "data": {
                "num_rows": 2,
                "num_cols": 1,
                "table_items": [
                    {
                        "text": "Related Trust Policies (to be read in conjunction with)"
                    },
                    {
                        "text": "Prescribing of Medicines Policy (or equivalent) Administration of Medicines Policy (or equivalent) All Trust policies and procedures for cytotoxic drugs (or equivalent) MSEPO-19014 Policy for Management of Incidents MSEPO-19015 Procedure Report Management of Incidents and Serious Incidents MSEPO-20206 Policy for the Management of and Learning from Medication Error Incidents"
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 7,
            "data": {
                "num_rows": 3,
                "num_cols": 3,
                "table_items": [
                    {
                        "text": "Document Review History:"
                    },
                    {
                        "text": "Version No:"
                    },
                    {
                        "text": "Authored/Reviewer:"
                    },
                    {
                        "text": "Summary of amendments/ Record documents superseded by:"
                    },
                    {
                        "text": "Issue Date:"
                    },
                    {
                        "text": "1.0"
                    },
                    {
                        "text": "Simon Worrall"
                    },
                    {
                        "text": "Harmonised for MSE-wide use. Replaces Southend MMP025 Policies for the Management of Intrathecal Chemotherapy and Basildon CPPO00136 Intrathecal Chemotherapy Policies. New document for Broomfield."
                    },
                    {
                        "text": "25 May 2021"
                    }
                ]
            }
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Contents"
            },
            "type": "ListItem",
            "sequence_num": 8
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 1.0,
                "text": "Introduction ................................................................................................................... 5"
            },
            "type": "ListItem",
            "sequence_num": 9
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 2.0,
                "text": "Scope ........................................................................................................................... 6"
            },
            "type": "ListItem",
            "sequence_num": 10
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 3.0,
                "text": "Definitions ..................................................................................................................... 6"
            },
            "type": "ListItem",
            "sequence_num": 11
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 4.0,
                "text": "Role & Responsibilities within the Trust ........................................................................ 6"
            },
            "type": "ListItem",
            "sequence_num": 12
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 5.0,
                "text": "General Principles and Key requirements .................................................................. 10"
            },
            "type": "ListItem",
            "sequence_num": 13
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 6.0,
                "text": "Register of Designated Personnel .............................................................................. 11"
            },
            "type": "ListItem",
            "sequence_num": 14
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 7.0,
                "text": "Being Prepared to Challenge ...................................................................................... 12"
            },
            "type": "ListItem",
            "sequence_num": 15
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 8.0,
                "text": "Protocols and Guidelines ............................................................................................ 12"
            },
            "type": "ListItem",
            "sequence_num": 16
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 30.0,
                "text": "Prescribing .................................................................................................................. 13  Intrathecal Chemotherapy Chart ................................................................................. 13  Verification .................................................................................................................. 13  Manufacture and Dispensing in the Pharmacy ........................................................... 14  Labelling and Packaging ............................................................................................. 14  Preparation and Dispensing on the Ward ................................................................... 14  Issuing and collection of ITC Drugs ............................................................................ 14  Timing of Issue of ITC Drugs ...................................................................................... 15  Packaging and Transportation .................................................................................... 15  Storage and Retrieval ................................................................................................. 15  Patient Review ............................................................................................................ 15  Administration and location of Designated areas ........................................................ 16  Checking ..................................................................................................................... 16  Times of Administration .............................................................................................. 17  Waivers ....................................................................................................................... 18  Waivers for junior and middle grades to administer intrathecal chemotherapy ........... 18  Record of Personnel Involvement ............................................................................... 18 Training Requirements ............................................................................................... 18  Monitoring and Audit ................................................................................................... 21  Approval and Implementation ..................................................................................... 21  Equality Impact Assessment ....................................................................................... 21  References ................................................................................................................. 22 Appendix 1: Preliminary Equality Analysis ......................................................................... 23"
            },
            "type": "ListItem",
            "sequence_num": 17
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 1.0,
                "text": "Introduction"
            },
            "type": "ListItem",
            "sequence_num": 18
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 1.1,
                "text": "At least 55 incidents are known to have occurred around the world (a number in England) where the intravenous vinca alkaloid drug vincristine has been injected intrathecally (via spinal injections) during the chemotherapy treatment of a cancer patient. These incidents have resulted in the paralysis or death of the patients involved. Vinca alkaloids (vincristine, vinblastine, vindesine and vinorelbine) are intended for intravenous use only. If injected intrathecally they cause paralysis almost always followed by death."
            },
            "type": "ListItem",
            "sequence_num": 19
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 1.2,
                "text": "The Government agreed a target to reduce the number of patients dying or being paralysed by maladministered spinal injections to zero by the end of 2001. This target was influenced both by the recommendations in \u201cAn Organisation with a Memory\u201d and by the publication of two reports on intrathecal injection errors. These were:"
            },
            "type": "ListItem",
            "sequence_num": 20
        },
        {
            "data": {
                "is_heading": 0,
                "text": "The Prevention of Intrathecal Medication Errors, Prof Kent Woods, April 2001;"
            },
            "type": "ListItem",
            "sequence_num": 21
        },
        {
            "data": {
                "is_heading": 0,
                "text": "The External Inquiry into the adverse incident that occurred at Queens Medical Centre, Nottingham, 4th January 2001, Prof Brian Toft, April 2001."
            },
            "type": "ListItem",
            "sequence_num": 22
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 1.3,
                "text": "Both reports made important recommendations. One of the recommendations of the Toft report was that national guidance should be developed and implemented so that practice would be uniform across the whole country. Staff moving from one Trust to another would not then have to adapt to a different procedure. National guidance (HSC 2001/022) was issued in November 2001, updated and reissued in October 2003 (HSC 2003/010). The National guidance has been further updated (HSC 2008/001) to include a number of issues identified through peer review processes."
            },
            "type": "ListItem",
            "sequence_num": 23
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 1.4,
                "text": "In August 2009 the NPSA issued the Patient Safety Alert NPSA/2009/PSA004A. This alert outlined the requirement to supply and administer Intrathecal Chemotherapy via a system of non-luer connectors to reduce further the risk of inadvertent administration of incorrect drugs via the spinal route. This alert was updated in August 2017 by NHS improvement after an international standard was developed (ISO 80369) for the safety connectors NHS/PSA/RE/2017/004."
            },
            "type": "ListItem",
            "sequence_num": 24
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 1.5,
                "text": "The safe administration of Intrathecal Chemotherapy is part of the Trust's clinical governance agenda."
            },
            "type": "ListItem",
            "sequence_num": 25
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 1.6,
                "text": "This policy covers the Intrathecal Chemotherapy service provided to the one division within the Trust \u2013 the Cancer Division. The service is not provided to any other division or to paediatric patients. It should be used in conjunction with other Trust policies and procedures for cytotoxic drugs (see section 8)."
            },
            "type": "ListItem",
            "sequence_num": 26
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 2.0,
                "text": "Scope"
            },
            "type": "ListItem",
            "sequence_num": 27
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 2.1,
                "text": "The purpose of this document is to:"
            },
            "type": "ListItem",
            "sequence_num": 28
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensure the Trust is compliant with national guidance on the management of intrathecal chemotherapy. In doing so it sets out how the Trust will ensure safe use of these medicines to minimise risks to patients."
            },
            "type": "ListItem",
            "sequence_num": 29
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 3.0,
                "text": "Definitions"
            },
            "type": "ListItem",
            "sequence_num": 30
        },
        {
            "type": "table",
            "sequence_num": 31,
            "data": {
                "num_rows": 10,
                "num_cols": 2,
                "table_items": [
                    {
                        "text": "TERM"
                    },
                    {
                        "text": "DEFINITION"
                    },
                    {
                        "text": "Vinca Alkaloid"
                    },
                    {
                        "text": "A class of drugs, including, but not exclusively, vincristine, vinblastine, vindesine and vinorelbine."
                    },
                    {
                        "text": "Intrathecal"
                    },
                    {
                        "text": "Administration into the spine"
                    },
                    {
                        "text": "MSE or \u2018the Trust'"
                    },
                    {
                        "text": "Mid & South Essex NHS Foundation Trust"
                    },
                    {
                        "text": "Guidance in HSC 2008/001"
                    },
                    {
                        "text": "National guidance provided in Health Service Circular HSC 2008/001 Updated National Guidance on the Safe Administration of Intrathecal Chemotherapy (August 2008)."
                    },
                    {
                        "text": "ITC"
                    },
                    {
                        "text": "Intrathecal chemotherapy"
                    },
                    {
                        "text": "CTUP"
                    },
                    {
                        "text": "Cytotoxic Unit Pharmacy"
                    },
                    {
                        "text": "SOP"
                    },
                    {
                        "text": "Standard operating procedures"
                    },
                    {
                        "text": "SACT"
                    },
                    {
                        "text": "Systemic Anti-Cancer Therapy"
                    },
                    {
                        "text": "NPSA"
                    },
                    {
                        "text": "National Patient Safety Agency"
                    }
                ]
            }
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 4.0,
                "text": "Role & Responsibilities within the Trust"
            },
            "type": "ListItem",
            "sequence_num": 32
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 4.1,
                "text": "MSE Patient Safety & Quality Group"
            },
            "type": "ListItem",
            "sequence_num": 33
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Receiving exception reports and taking action in response to issues raised from Medicines Assurance Group and/or department of pharmacy."
            },
            "type": "ListItem",
            "sequence_num": 34
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 4.2,
                "text": "MSE Medicines Assurance Group (MAG)"
            },
            "type": "ListItem",
            "sequence_num": 35
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensuring the effective implementation, use and timely review of this policy;"
            },
            "type": "ListItem",
            "sequence_num": 36
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensuring that monitoring arrangements are appropriately performed by the Site Medicines Optimisation and Safety Groups (MOSG);"
            },
            "type": "ListItem",
            "sequence_num": 37
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Where necessary, escalating concerns to the Chief Nursing Officer, site Director of Nursing, Deputy Director of Nursing for Cancer or Chief Medical Officer, site Medical Director, Clinical Director for Oncology as appropriate;"
            },
            "type": "ListItem",
            "sequence_num": 38
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Exception reporting to the MSE Patient Safety & Quality Group on developments, concerns and progress concerning Intrathecal Chemotherapy use."
            },
            "type": "ListItem",
            "sequence_num": 39
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 4.3,
                "text": "Site Medicines Optimisation and Safety Group (MOSG)"
            },
            "type": "ListItem",
            "sequence_num": 40
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Monitoring this policy through incident reports;"
            },
            "type": "ListItem",
            "sequence_num": 41
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Facilitating feedback of relevant actions from the MSE SACT Quality Group and designated leads as appropriate."
            },
            "type": "ListItem",
            "sequence_num": 42
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Escalating issues to Cancer division governance group/s and MAG as appropriate."
            },
            "type": "ListItem",
            "sequence_num": 43
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 4.4,
                "text": "MSE SACT Quality Group"
            },
            "type": "ListItem",
            "sequence_num": 44
        },
        {
            "data": {
                "is_heading": 0,
                "text": "On-going review and implementation of processes outlined within this document;"
            },
            "type": "ListItem",
            "sequence_num": 45
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensuring that follow-up and investigation of intrathecal medicine incidents is completed in accordance with Trust policies for incident management (MSEPO- 19014 & 19015, and medication errors MSEPO-20206;"
            },
            "type": "ListItem",
            "sequence_num": 46
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensuring audits are undertaken and action plans are developed and completed in an appropriate and timely manner;"
            },
            "type": "ListItem",
            "sequence_num": 47
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Facilitating feedback with any actions taken and recommendations for changes in practice;"
            },
            "type": "ListItem",
            "sequence_num": 48
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Reviewing this policy annually to ensure it remains up to date and relevant."
            },
            "type": "ListItem",
            "sequence_num": 49
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 4.5,
                "text": "Chief Executive"
            },
            "type": "ListItem",
            "sequence_num": 50
        },
        {
            "data": {
                "is_heading": 0,
                "text": "As the Trust's accountable officer has overall responsibility for ensuring the Trust has robust, complete and up to date documents in place to govern and guide activities so that legal, and national requirements are met."
            },
            "type": "ListItem",
            "sequence_num": 51
        },
        {
            "data": {
                "is_heading": 0,
                "text": "The overall responsibility for compliance with Guidance in HSC 2008/001. To ensure compliance of national guidance the Chief Executive will identify a single lead who will be accountable to them for the issue of Intrathecal Chemotherapy (ITC);"
            },
            "type": "ListItem",
            "sequence_num": 52
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Countersigning, where appropriate, a waiver of this policy for junior and middle grades to administer intrathecal chemotherapy (see section 24)."
            },
            "type": "ListItem",
            "sequence_num": 53
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 4.6,
                "text": "Chief Medical Officer"
            },
            "type": "ListItem",
            "sequence_num": 54
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensuring that there is policy compliance and liaising with the site Medical Directors and Clinical Director for Oncology that the service is operating effectively;"
            },
            "type": "ListItem",
            "sequence_num": 55
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensuring sufficient resources are in place to implement this policy;"
            },
            "type": "ListItem",
            "sequence_num": 56
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensuring any escalated intrathecal chemotherapy issues involving professions they oversee are appropriately managed corporately."
            },
            "type": "ListItem",
            "sequence_num": 57
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 4.7,
                "text": "Site Medical Directors"
            },
            "type": "ListItem",
            "sequence_num": 58
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensuring that there is policy compliance on site by all professions they oversee and that the service is operating effectively;"
            },
            "type": "ListItem",
            "sequence_num": 59
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensuring any escalated intrathecal chemotherapy issues involving professions they oversee are appropriately managed corporately."
            },
            "type": "ListItem",
            "sequence_num": 60
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Countersigning, where appropriate, any waiver of this policy for junior and middle grade intrathecal chemotherapy (see sections 23 and 24). Informing the Chief Medical Officer and Chief Executive immediately."
            },
            "type": "ListItem",
            "sequence_num": 61
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 4.8,
                "text": "Cancer Division Medical Director"
            },
            "type": "ListItem",
            "sequence_num": 62
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensuring prescribers are implementing and monitoring intrathecal chemotherapy management in their areas;"
            },
            "type": "ListItem",
            "sequence_num": 63
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensuring areas under their responsibility are appropriately monitored and supported following audit to ensure sustained improvement is achieved;"
            },
            "type": "ListItem",
            "sequence_num": 64
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Reviewing and escalating any requests for waiver to site Medical Director."
            },
            "type": "ListItem",
            "sequence_num": 65
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 4.9,
                "text": "Chief Nursing Officer"
            },
            "type": "ListItem",
            "sequence_num": 66
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensuring that there is policy compliance and liaising with the Chief Pharmacist to ensure the service is operating effectively;"
            },
            "type": "ListItem",
            "sequence_num": 67
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensuring sufficient resources are in place to implement this policy;"
            },
            "type": "ListItem",
            "sequence_num": 68
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensuring any escalated intrathecal chemotherapy issues involving professions they oversee are appropriately managed corporately."
            },
            "type": "ListItem",
            "sequence_num": 69
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 4.1,
                "text": "Site Director of Nursing"
            },
            "type": "ListItem",
            "sequence_num": 70
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensuring that there is policy compliance on site by all professions they oversee and that the service is operating effectively;"
            },
            "type": "ListItem",
            "sequence_num": 71
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensuring any escalated intrathecal chemotherapy issues involving professions they oversee are appropriately managed corporately;"
            },
            "type": "ListItem",
            "sequence_num": 72
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensuring sufficient resources are in place to implement this policy;"
            },
            "type": "ListItem",
            "sequence_num": 73
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Countersigning, where appropriate, a waiver of this policy for junior and middle grades to administer intrathecal chemotherapy (see section 24). Informing the Chief Nursing Officer immediately."
            },
            "type": "ListItem",
            "sequence_num": 74
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 4.11,
                "text": "Deputy Director of Nursing for Cancer"
            },
            "type": "ListItem",
            "sequence_num": 75
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensuring that there is policy compliance on all sites by all professions they oversee and that the service is operating effectively;"
            },
            "type": "ListItem",
            "sequence_num": 76
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensuring any escalated intrathecal chemotherapy issues involving professions they oversee are appropriately managed corporately;"
            },
            "type": "ListItem",
            "sequence_num": 77
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensuring sufficient resources are in place to implement this policy;"
            },
            "type": "ListItem",
            "sequence_num": 78
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Providing assurance to each site Director of Nursing and Chief Nursing Officer that the division is fully complying with this policy with respect to nursing practice."
            },
            "type": "ListItem",
            "sequence_num": 79
        },
        {
            "data": {
                "is_heading": 0,
                "text": "The Deputy Director of Nursing for Cancer may delegate aspects to the Associate Director of Nursing for Oncology, though responsibility and accountability remains with them."
            },
            "type": "ListItem",
            "sequence_num": 80
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 4.12,
                "text": "Chief Pharmacist"
            },
            "type": "ListItem",
            "sequence_num": 81
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Setting the overall framework and policy standards for intrathecal chemotherapy across the organisation, in line with regulatory and best practice guidance;"
            },
            "type": "ListItem",
            "sequence_num": 82
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensuring a monitoring process exists and functions for policy standard."
            },
            "type": "ListItem",
            "sequence_num": 83
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Countersigning, where appropriate, a waiver of this policy for junior and middle grades to administer intrathecal chemotherapy (see section 24)."
            },
            "type": "ListItem",
            "sequence_num": 84
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Delegated Deputy to holding the register and in particular at Southend site and ensuring that it is maintained and kept up to date;"
            },
            "type": "ListItem",
            "sequence_num": 85
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 4.13,
                "text": "The Designated Intrathecal (ITC) Lead"
            },
            "type": "ListItem",
            "sequence_num": 86
        },
        {
            "data": {
                "is_heading": 0,
                "text": "They are accountable to the Chief Executive for the compliance with the National ITC guidance and peer review measures."
            },
            "type": "ListItem",
            "sequence_num": 87
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Having overall responsibility for co-ordinating induction, training, annual review and continuing professional development related to intrathecal chemotherapy (Local Leads) and this should be reflected in their job description;"
            },
            "type": "ListItem",
            "sequence_num": 88
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Holding the register and ensuring that it is maintained and kept up to date;"
            },
            "type": "ListItem",
            "sequence_num": 89
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Countersigning, where appropriate, a waiver of this policy for junior and middle grades to administer intrathecal chemotherapy (see section 24)."
            },
            "type": "ListItem",
            "sequence_num": 90
        },
        {
            "data": {
                "is_heading": 0,
                "text": "The Designated ITC Lead may delegate day to day responsibility for maintaining individual aspects of the register, training, CPD and annual review to other senior staff pertinent to their role within the procedure."
            },
            "type": "ListItem",
            "sequence_num": 91
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 4.14,
                "text": "The \u2018Local Leads' for Intrathecal Chemotherapy: Medical, Nursing and Pharmacy respectively"
            },
            "type": "ListItem",
            "sequence_num": 92
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensuring all newly appointed medical, nursing and pharmacy staff receive induction, training and continuing professional development related to intrathecal chemotherapy;"
            },
            "type": "ListItem",
            "sequence_num": 93
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensuring that appropriate and adequate staff is present on each register, including new staff joining the Trust, and for staff leaving the Trust;"
            },
            "type": "ListItem",
            "sequence_num": 94
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensuring that all medical, nursing and pharmacy staff on the register are able to demonstrate competency in prescribing/administering intrathecal chemotherapy and that this competence is reviewed annually;"
            },
            "type": "ListItem",
            "sequence_num": 95
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Authorising the entry of an eligible member of their staff onto the Trust register for ITC, as delegated by the designated ITC Lead;"
            },
            "type": "ListItem",
            "sequence_num": 96
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Deleting a staff member from the Trust ITC register, if at an annual review or at any other time of assessment, is no longer competent, or deemed to have not achieved the required level of competency to perform their registered task."
            },
            "type": "ListItem",
            "sequence_num": 97
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 4.15,
                "text": "The Nursing and Pharmacy Local Leads (Lead Trainers)"
            },
            "type": "ListItem",
            "sequence_num": 98
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Delivering training programs and annual review in accordance with the requirements of this policy for medical, nursing and pharmacy staff."
            },
            "type": "ListItem",
            "sequence_num": 99
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 4.16,
                "text": "Site Lead Pharmacist for Oncology and Haematology"
            },
            "type": "ListItem",
            "sequence_num": 100
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensuring that prescriptions comply with Guidance in HSC 2008/001."
            },
            "type": "ListItem",
            "sequence_num": 101
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 4.17,
                "text": "MSE Head of Pharmacy Technical Services"
            },
            "type": "ListItem",
            "sequence_num": 102
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensuring that Intrathecal Chemotherapy doses are labelled and supplied in accordance with this policy during the dose manufacturing process(s)."
            },
            "type": "ListItem",
            "sequence_num": 103
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 4.18,
                "text": "All prescribers involved in the prescribing of Intrathecal Chemotherapy"
            },
            "type": "ListItem",
            "sequence_num": 104
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensuring they always comply with the requirements of this policy and ensure all prescriptions / written orders are written in accordance with the law."
            },
            "type": "ListItem",
            "sequence_num": 105
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 4.19,
                "text": "All Staff involved in intrathecal medication"
            },
            "type": "ListItem",
            "sequence_num": 106
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Compliance with the policy specifically applies to all medical, Nursing and Pharmacy staff that have been appropriately trained in the intrathecal chemotherapy process. It is the responsibility of these staff to make sure that only staff currently on the intrathecal register are involved in the process."
            },
            "type": "ListItem",
            "sequence_num": 107
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Failure to follow this policy at any stage relating to intrathecal chemotherapy is classified as a medication incident. All errors or near miss events relating to intrathecal chemotherapy MUST be brought to the attention of the senior medical, nursing staff and pharmacy leads immediately."
            },
            "type": "ListItem",
            "sequence_num": 108
        },
        {
            "data": {
                "is_heading": 0,
                "text": "An incident form MUST be completed immediately clearly stating \u201cintrathecal chemotherapy\u201d on the Trust incident reporting system (please refer Trust policies for incident management (MSEPO-19014 & 19015, and medication errors MSEPO-20206)."
            },
            "type": "ListItem",
            "sequence_num": 109
        },
        {
            "data": {
                "is_heading": 0,
                "text": "All staff involved with the care and treatment of patients receiving chemotherapy are permitted to challenge colleagues. They may do this, if in their judgement, policies on the safe administration of intrathecal chemotherapy or intravenous chemotherapy are not being adhered to, or if the actions of an individual may cause potential risk to a patient. In the event of a colleague persisting in an obviously hazardous action, a senior colleague should be summoned immediately to advise and assist, and the potentially hazardous procedure delayed until further checks by a senior colleague have been made and a safe course of action agreed."
            },
            "type": "ListItem",
            "sequence_num": 110
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 5.0,
                "text": "General Principles and Key requirements"
            },
            "type": "ListItem",
            "sequence_num": 111
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 5.1,
                "text": "No deviation from this policy is allowed in the prescribing, dispensing, checking, delivery and administration of Intrathecal chemotherapy"
            },
            "type": "ListItem",
            "sequence_num": 112
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 5.2,
                "text": "Only trained, designated personnel whose names are recorded in the Intrathecal Chemotherapy register are authorised to prescribe, dispense (including manufacture and issue check), check or administer Intrathecal Chemotherapy"
            },
            "type": "ListItem",
            "sequence_num": 113
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 5.3,
                "text": "Within the Trust Intrathecal Chemotherapy may be administered to adult patients only, in an area and at a time designated for this purpose for the entire session. Where more than one patient per day is being treated these should be planned to run sequentially in one session."
            },
            "type": "ListItem",
            "sequence_num": 114
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 5.4,
                "text": "All new staff must undertake a formal induction programme that is appropriate to their role, and annual updates must be provided for all professional staff to remain on the intrathecal register."
            },
            "type": "ListItem",
            "sequence_num": 115
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 5.5,
                "text": "Staff involved with chemotherapy must be provided with a copy of this document together with accompanying guidance."
            },
            "type": "ListItem",
            "sequence_num": 116
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 5.6,
                "text": "Staff should be given a certificate on satisfactory completion of their training, the expiry date reflecting the expected interval before review, normally one year."
            },
            "type": "ListItem",
            "sequence_num": 117
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 5.7,
                "text": "Intrathecal Chemotherapy must be prescribed by a certificated Consultant, or Specialist Registrar at grade ST3 and above only and using the designated intrathecal protocol on the electronic prescribing system ChemoCare."
            },
            "type": "ListItem",
            "sequence_num": 118
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 5.8,
                "text": "Intrathecal Chemotherapy drugs must be issued and received by designated staff only. Any such products not used must be returned to pharmacy at once."
            },
            "type": "ListItem",
            "sequence_num": 119
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 5.9,
                "text": "Intrathecal Chemotherapy drugs must be provided in and administered via a system of NRFit\u2122 connectors that will NOT connect to intravenous equipment."
            },
            "type": "ListItem",
            "sequence_num": 120
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 5.1,
                "text": "Any Intravenous drugs due must be administered BEFORE intrathecal drugs are issued. Any continuous infusional chemotherapy due must already be in progress."
            },
            "type": "ListItem",
            "sequence_num": 121
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 5.11,
                "text": "Intrathecal Chemotherapy must be administered in a designated, separate room at a time designated for this purpose within normal working hours."
            },
            "type": "ListItem",
            "sequence_num": 122
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 5.12,
                "text": "Checks must be made by designated medical, nursing and pharmacy staff at relevant stages throughout the prescribing, preparation, dispensing and administration process."
            },
            "type": "ListItem",
            "sequence_num": 123
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 5.13,
                "text": "All chemotherapy drugs must have the route of administration clearly labelled."
            },
            "type": "ListItem",
            "sequence_num": 124
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 6.0,
                "text": "Register of Designated Personnel"
            },
            "type": "ListItem",
            "sequence_num": 125
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 6.1,
                "text": "Within the Cancer Division, in which Intrathecal Chemotherapy is given, a single site specific register will be maintained, by the Designated Lead, of certificated personnel (medical, nursing and pharmacy staff) who have been trained and certified competent in one or more of the following tasks:"
            },
            "type": "ListItem",
            "sequence_num": 126
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Prescribing;"
            },
            "type": "ListItem",
            "sequence_num": 127
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Prescription Verification;"
            },
            "type": "ListItem",
            "sequence_num": 128
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Dispensing;"
            },
            "type": "ListItem",
            "sequence_num": 129
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Issuing;"
            },
            "type": "ListItem",
            "sequence_num": 130
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Checking;"
            },
            "type": "ListItem",
            "sequence_num": 131
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Administration."
            },
            "type": "ListItem",
            "sequence_num": 132
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 6.2,
                "text": "Two Intrathecal Chemotherapy trained senior staff are designated training leads for the Trust. They have joint and equal responsibility for training and assessing competence of all grades of appropriate staff by means of a quarterly cycle of training sessions."
            },
            "type": "ListItem",
            "sequence_num": 133
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 6.3,
                "text": "For an individual's name to appear on the register they must have demonstrated that they are competent in the understanding of the processes and procedures governing intrathecal chemotherapy, both national and locally, to enable them fulfil their designated role(s)."
            },
            "type": "ListItem",
            "sequence_num": 134
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 6.4,
                "text": "Only the designated ITC lead or the named local training leads/competency assessors and Chief Pharmacist are permitted, as delegated by the ITC lead, to authorise entry of an eligible person on to that part of the register for that respective task and to delete from the register any person deemed to have not achieved the required level of competency assessment."
            },
            "type": "ListItem",
            "sequence_num": 135
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 6.5,
                "text": "The \u2018Local Leads' are responsible for ensuring that appropriate and adequate staff is present on each register, including new staff joining the Trust, and for staff leaving the Trust."
            },
            "type": "ListItem",
            "sequence_num": 136
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 6.6,
                "text": "The responsibility for the maintenance and update of the register lies with the Designated ITC lead, and or Chief Pharmacist on the Southend site, as delegated by the ITC lead and is subject to document control."
            },
            "type": "ListItem",
            "sequence_num": 137
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 6.7,
                "text": "Copies of the current registers will be available in all areas where Intrathecal Chemotherapy is prepared or administered."
            },
            "type": "ListItem",
            "sequence_num": 138
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 6.8,
                "text": "Only those staff members named on the register for a given task are permitted to perform that task, except for the following sole conditions as specified below:"
            },
            "type": "ListItem",
            "sequence_num": 139
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 6.9,
                "text": "Personnel who have intent to go on the register may perform a given registerable task under the direct supervision of, and in the constant presence when performing it of, personnel who are agreed as Trust competency assessors for that task when it is being performed as part of the Intrathecal Chemotherapy registration training programme, competency review or refresher training."
            },
            "type": "ListItem",
            "sequence_num": 140
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 7.0,
                "text": "Being Prepared to Challenge"
            },
            "type": "ListItem",
            "sequence_num": 141
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 7.1,
                "text": "All staff involved with the care and treatment of patients receiving chemotherapy must be encouraged to challenge colleagues, no matter how senior their position, if in their judgement, either protocols are not being adhered to, or the actions of an individual may cause potential risk to a patient."
            },
            "type": "ListItem",
            "sequence_num": 142
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 7.2,
                "text": "Challenging of a colleague should not be seen as adversarial, but as an additional check to improve patient safety and reduce risk."
            },
            "type": "ListItem",
            "sequence_num": 143
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 7.3,
                "text": "Each individual staff member on the ITC register must ensure that they only involve other members of staff in the specific intrathecal chemotherapy administration tasks for which those individual are designated on ITC register."
            },
            "type": "ListItem",
            "sequence_num": 144
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 8.0,
                "text": "Protocols and Guidelines"
            },
            "type": "ListItem",
            "sequence_num": 145
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 8.1,
                "text": "The policies and procedures with regards to Intrathecal Chemotherapy include:"
            },
            "type": "ListItem",
            "sequence_num": 146
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Prescribing;"
            },
            "type": "ListItem",
            "sequence_num": 147
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Verification;"
            },
            "type": "ListItem",
            "sequence_num": 148
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Dispensing;"
            },
            "type": "ListItem",
            "sequence_num": 149
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Issuing;"
            },
            "type": "ListItem",
            "sequence_num": 150
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Checking;"
            },
            "type": "ListItem",
            "sequence_num": 151
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Administration."
            },
            "type": "ListItem",
            "sequence_num": 152
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 8.2,
                "text": "The policies and procedures must be made available to all members of staff involved in Intrathecal Chemotherapy at induction. They must be included in training for all staff. These procedures must warn that chemotherapy drugs given by the incorrect route may be fatal."
            },
            "type": "ListItem",
            "sequence_num": 153
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 8.3,
                "text": "These documents will include information on:"
            },
            "type": "ListItem",
            "sequence_num": 154
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Who can do what (i.e. the register);"
            },
            "type": "ListItem",
            "sequence_num": 155
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Where things should be done (e.g. names of wards/other designated areas etc.);"
            },
            "type": "ListItem",
            "sequence_num": 156
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Where to find key documents such as national guidance and local relevant protocols."
            },
            "type": "ListItem",
            "sequence_num": 157
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 8.4,
                "text": "Only the latest editions of policies and procedures must be available. Copies will be lodged in appropriate locations where they may be required for consultation to ensure ease of access."
            },
            "type": "ListItem",
            "sequence_num": 158
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 9.0,
                "text": "Prescribing"
            },
            "type": "ListItem",
            "sequence_num": 159
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 9.1,
                "text": "Only a certificated Consultant, or certificated Specialist Registrar at grade ST3 and above, is allowed to prescribe Intrathecal Chemotherapy."
            },
            "type": "ListItem",
            "sequence_num": 160
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 9.2,
                "text": "This route of drug administration must be prescribed ONLY on ChemoCare using the designated intrathecal protocol."
            },
            "type": "ListItem",
            "sequence_num": 161
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 10.0,
                "text": "Intrathecal Chemotherapy Chart"
            },
            "type": "ListItem",
            "sequence_num": 162
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 10.1,
                "text": "There is a specific ChemoCare protocol for intrathecal methotrexate, which must be used in all instances where Intrathecal Chemotherapy is prescribed."
            },
            "type": "ListItem",
            "sequence_num": 163
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 10.2,
                "text": "The drugs and the route of administration are fixed."
            },
            "type": "ListItem",
            "sequence_num": 164
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 10.3,
                "text": "The chart has space to allow for the signatures of all staff involved in the prescribing, verification, dispensing, checking and administration."
            },
            "type": "ListItem",
            "sequence_num": 165
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 11.0,
                "text": "Verification"
            },
            "type": "ListItem",
            "sequence_num": 166
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 11.1,
                "text": "Each prescription for Intrathecal Chemotherapy must be verified as accurate in all respects by a trained and certificated registered pharmacist."
            },
            "type": "ListItem",
            "sequence_num": 167
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 12.0,
                "text": "Manufacture and Dispensing in the Pharmacy"
            },
            "type": "ListItem",
            "sequence_num": 168
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 12.1,
                "text": "Intrathecal drugs may only be prepared during normal working hours, Monday to Friday, excluding Bank Holidays to ensure administration between normal working hours."
            },
            "type": "ListItem",
            "sequence_num": 169
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 12.2,
                "text": "Intrathecal drugs can only be manufactured/dispensed in the CTU Pharmacy and issued from pharmacy by trained and certificated pharmacy staff in accordance with internal SOPs."
            },
            "type": "ListItem",
            "sequence_num": 170
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 12.3,
                "text": "Intrathecal Chemotherapy drugs must only be supplied in syringes using a dedicated NRFit\u2122 connector system that conforms to ISO 80369 and will not connect with intravenous equipment (Patient Safety Alert NHS/PSA/RE/2017/004)."
            },
            "type": "ListItem",
            "sequence_num": 171
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 13.0,
                "text": "Labelling and Packaging"
            },
            "type": "ListItem",
            "sequence_num": 172
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 13.1,
                "text": "Labels added in Pharmacy must show the patient name, hospital number, product name, dose and the route of administration printed clearly in a large bold font size within the limitations of the computer system and the overall appearance of the label i.e. the legibility of the drug name and dose must not be compromised."
            },
            "type": "ListItem",
            "sequence_num": 173
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 13.2,
                "text": "Negative expressions for the route of administration must never be used on labels."
            },
            "type": "ListItem",
            "sequence_num": 174
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 14.0,
                "text": "Preparation and Dispensing on the Ward"
            },
            "type": "ListItem",
            "sequence_num": 175
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 14.1,
                "text": "Intrathecal Chemotherapy drugs must never be made up on wards except in exceptional circumstances, such as emergency cases of central nervous system (CNS) relapse leukaemia outside of normal working hours where there are no available certificated pharmacy staff available."
            },
            "type": "ListItem",
            "sequence_num": 176
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 14.2,
                "text": "In such cases, pharmacy staff should provide support and advice to achieve safe preparation at ward level."
            },
            "type": "ListItem",
            "sequence_num": 177
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 14.3,
                "text": "Drug MUST be prepared by chemotherapy-trained registered nurse."
            },
            "type": "ListItem",
            "sequence_num": 178
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 14.4,
                "text": "A waiver must be completed and the designated lead for ITC informed of the procedure."
            },
            "type": "ListItem",
            "sequence_num": 179
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 15.0,
                "text": "Issuing and collection of ITC Drugs"
            },
            "type": "ListItem",
            "sequence_num": 180
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 15.1,
                "text": "Drugs for Intrathecal Chemotherapy must only be issued from CTU Pharmacy directly to a doctor whose name appears in the register or taken to the ward by a pharmacist whose name appears on the register for dispensing Intrathecal Chemotherapy."
            },
            "type": "ListItem",
            "sequence_num": 181
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 15.2,
                "text": "If the drugs are taken to the ward, they must be issued directly to the doctor who will be administering the chemotherapy."
            },
            "type": "ListItem",
            "sequence_num": 182
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 15.3,
                "text": "In all instances, the member of pharmacy staff must sign for the release of the drugs and the doctor must also sign for the receipt of this handover."
            },
            "type": "ListItem",
            "sequence_num": 183
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 16.0,
                "text": "Timing of Issue of ITC Drugs"
            },
            "type": "ListItem",
            "sequence_num": 184
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 16.1,
                "text": "Local policy dictates that Intrathecal Chemotherapy MUST NOT be administered on the same day as intravenous chemotherapy for a particular patient."
            },
            "type": "ListItem",
            "sequence_num": 185
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 16.2,
                "text": "Only following written proof, that any intravenous cytotoxic drugs for the named patient have already been administered; such as a copy of the prescription chart and the signed section on the intrathecal prescription; should the intrathecal drug be issued."
            },
            "type": "ListItem",
            "sequence_num": 186
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 16.3,
                "text": "Issuer and collector must sign the dedicated chemotherapy chart."
            },
            "type": "ListItem",
            "sequence_num": 187
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 16.4,
                "text": "In the rare occurrence that ITC is to be administered concurrently with continuous intravenous chemotherapy, the Intrathecal Chemotherapy will only be issued once there is evidence that the infusional chemotherapy has commenced."
            },
            "type": "ListItem",
            "sequence_num": 188
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 17.0,
                "text": "Packaging and Transportation"
            },
            "type": "ListItem",
            "sequence_num": 189
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 17.1,
                "text": "Intrathecal Chemotherapy drugs must always be packed and transported in designated packaging in accordance with internal SOPs, separately from treatments for administration by other routes."
            },
            "type": "ListItem",
            "sequence_num": 190
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 17.2,
                "text": "Refer to section 15 in regards to issuing and collection."
            },
            "type": "ListItem",
            "sequence_num": 191
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 18.0,
                "text": "Storage and Retrieval"
            },
            "type": "ListItem",
            "sequence_num": 192
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 18.1,
                "text": "Intrathecal drugs must not be stored on wards. Intrathecal Chemotherapy drugs must be retained in the CTU Pharmacy and only be released shortly before administration."
            },
            "type": "ListItem",
            "sequence_num": 193
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 18.2,
                "text": "If for any reason the administration does not occur, the drugs must be returned at once to the CTU Pharmacy for management."
            },
            "type": "ListItem",
            "sequence_num": 194
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 19.0,
                "text": "Patient Review"
            },
            "type": "ListItem",
            "sequence_num": 195
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 19.1,
                "text": "A Consultant or an appropriately trained nominated deputy from the register of designated personnel must review patients before Intrathecal Chemotherapy is administered. This is to ensure that:"
            },
            "type": "ListItem",
            "sequence_num": 196
        },
        {
            "data": {
                "is_heading": 0,
                "text": "The patient is fit for treatment;"
            },
            "type": "ListItem",
            "sequence_num": 197
        },
        {
            "data": {
                "is_heading": 0,
                "text": "The correct tests have been conducted;"
            },
            "type": "ListItem",
            "sequence_num": 198
        },
        {
            "data": {
                "is_heading": 0,
                "text": "The correct chemotherapy has been prescribed;"
            },
            "type": "ListItem",
            "sequence_num": 199
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Arrangements have been clearly made for the chemotherapy to be administered by the appropriate medical staff."
            },
            "type": "ListItem",
            "sequence_num": 200
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 19.2,
                "text": "The person administering the drug must check that staff assisting them are on the ITC register."
            },
            "type": "ListItem",
            "sequence_num": 201
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 20.0,
                "text": "Administration and location of Designated areas"
            },
            "type": "ListItem",
            "sequence_num": 202
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 20.1,
                "text": "Intrathecal Chemotherapy must NEVER be administered on the Broomfield site"
            },
            "type": "ListItem",
            "sequence_num": 203
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 20.2,
                "text": "Intrathecal Chemotherapy may be administered only to adult patients on"
            },
            "type": "ListItem",
            "sequence_num": 204
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Elizabeth Loury ward (Southend Site), or"
            },
            "type": "ListItem",
            "sequence_num": 205
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Southend Chemotherapy Unit (Southend Site) , or"
            },
            "type": "ListItem",
            "sequence_num": 206
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Room 16 Ambulatory Care Unit (Basildon Site)."
            },
            "type": "ListItem",
            "sequence_num": 207
        },
        {
            "data": {
                "is_heading": 1,
                "text": "and at a time designated for this purpose."
            },
            "type": "ListItem",
            "sequence_num": 208
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 20.3,
                "text": "Intrathecal Chemotherapy must only be administered using a system of NRFit\u2122 connectors i.e. doses provided in NRFit\u2122 syringes and administered using NRFit\u2122 connector spinal needles."
            },
            "type": "ListItem",
            "sequence_num": 209
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 20.4,
                "text": "Intrathecal drugs must only be administered by a Consultant or Specialist Registrar at grade ST3 or above, who is named on the register of designated personnel."
            },
            "type": "ListItem",
            "sequence_num": 210
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 20.5,
                "text": "Intrathecal Chemotherapy must be administered in a single bedded room where no other chemotherapy drugs are currently being administered, except when infusional chemotherapy is running."
            },
            "type": "ListItem",
            "sequence_num": 211
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 20.6,
                "text": "The room must be designated for the administration of Intrathecal Chemotherapy over a specified period of time."
            },
            "type": "ListItem",
            "sequence_num": 212
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 20.7,
                "text": "When Intrathecal Chemotherapy is being administered, the room must NOT be used for any other purpose."
            },
            "type": "ListItem",
            "sequence_num": 213
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 20.8,
                "text": "Under no circumstances must chemotherapy drugs for intravenous use be stored in this room."
            },
            "type": "ListItem",
            "sequence_num": 214
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 21.0,
                "text": "Checking"
            },
            "type": "ListItem",
            "sequence_num": 215
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 21.1,
                "text": "Clinical staff, when preparing to treat a patient with Intrathecal Chemotherapy, must use a formal checking procedure to ensure that the correct drug and dose is being given to the right patient. The checking procedure must include the following checks and be undertaken only by staff that are on the register permitting them to undertake this task:"
            },
            "type": "ListItem",
            "sequence_num": 216
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Product details match the prescription chart \u2013 patient details and drug details;"
            },
            "type": "ListItem",
            "sequence_num": 217
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Product is in date and suitable for use;"
            },
            "type": "ListItem",
            "sequence_num": 218
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Product and prescription chart are for the correct patient;"
            },
            "type": "ListItem",
            "sequence_num": 219
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensure that the NRFit\u2122 spinal needle connector is compatible (i.e. uses the same connector system) with the NRFit\u2122 syringes used to provide the ready- made doses."
            },
            "type": "ListItem",
            "sequence_num": 220
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 21.2,
                "text": "The persons carrying out the checks must include:"
            },
            "type": "ListItem",
            "sequence_num": 221
        },
        {
            "data": {
                "is_heading": 0,
                "text": "The doctor administering the drug;"
            },
            "type": "ListItem",
            "sequence_num": 222
        },
        {
            "data": {
                "is_heading": 0,
                "text": "A chemotherapy-trained nurse;"
            },
            "type": "ListItem",
            "sequence_num": 223
        },
        {
            "data": {
                "is_heading": 0,
                "text": "The patient, if appropriate;"
            },
            "type": "ListItem",
            "sequence_num": 224
        },
        {
            "data": {
                "is_heading": 0,
                "text": "And, if appropriate, a patient relative or guardian."
            },
            "type": "ListItem",
            "sequence_num": 225
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Checks by two doctors alone is NEVER permitted."
            },
            "type": "ListItem",
            "sequence_num": 226
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 21.3,
                "text": "Patients must be explicitly told the nature of the procedure, the route of administration and the drug to be administered in order to add another safety check to the process."
            },
            "type": "ListItem",
            "sequence_num": 227
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 21.4,
                "text": "The checks made must be recorded, and a consent form is to be signed."
            },
            "type": "ListItem",
            "sequence_num": 228
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 21.5,
                "text": "A suitable record of the date, time, person administering the drug and two checkers must be made on the prescription chart."
            },
            "type": "ListItem",
            "sequence_num": 229
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 22.0,
                "text": "Times of Administration"
            },
            "type": "ListItem",
            "sequence_num": 230
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 22.1,
                "text": "Under normal circumstances, Intrathecal Chemotherapy must only be administered within normal working hours, 9.00am \u2013 5.00pm, Monday to Friday, excluding Bank Holidays."
            },
            "type": "ListItem",
            "sequence_num": 231
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 22.2,
                "text": "Only in the most exceptional circumstances (e.g. CNS relapse of leukaemia requiring emergency treatment) can Intrathecal Chemotherapy be given out of hours. In these instances, there must be a clear medical need for the procedure to be undertaken and the drug must be prescribed by a certificated Consultant Haematologist and waiver countersigned by the Medical Director (see section 23)."
            },
            "type": "ListItem",
            "sequence_num": 232
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 22.3,
                "text": "If a supply is made out of hours the on-call pharmacist must provide details of the supply to the site Lead Pharmacist Oncology/Haematology to ensure the out of hours records are completed accordingly. The Deputy / Chief Pharmacist must be informed."
            },
            "type": "ListItem",
            "sequence_num": 233
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 22.4,
                "text": "If a patient should be late for their appointment but their arrival is still within normal working hours, there must be sufficient flexibility in the ward's working arrangements to allow their treatment to proceed provided that there is sufficient appropriately certificated staff to proceed safely."
            },
            "type": "ListItem",
            "sequence_num": 234
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 22.5,
                "text": "However, if a patient arrives for their planned chemotherapy out of normal working hours, then a new appointment must be made."
            },
            "type": "ListItem",
            "sequence_num": 235
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 23.0,
                "text": "Waivers"
            },
            "type": "ListItem",
            "sequence_num": 236
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 23.1,
                "text": "In exceptional circumstances, if Intrathecal Chemotherapy is required outside current guidelines, a waiver form (CMS 006) must be completed and countersigned by the site Medical Director. This must include the full reasons for non-compliance with current guidelines."
            },
            "type": "ListItem",
            "sequence_num": 237
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 23.2,
                "text": "The waiver must be completed and presented to the pharmacy before drugs can be released."
            },
            "type": "ListItem",
            "sequence_num": 238
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 23.3,
                "text": "The waiver must be photocopied and a copy attached to the prescription chart. The original copy must be sent to the Designated ITC Lead for information and action."
            },
            "type": "ListItem",
            "sequence_num": 239
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 24.0,
                "text": "Waivers for junior and middle grades to administer intrathecal"
            },
            "type": "ListItem",
            "sequence_num": 240
        },
        {
            "data": {
                "is_heading": 1,
                "text": "chemotherapy"
            },
            "type": "ListItem",
            "sequence_num": 241
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 24.1,
                "text": "ST1 and ST2 staff are NEVER permitted to participate in intrathecal chemotherapy."
            },
            "type": "ListItem",
            "sequence_num": 242
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 24.2,
                "text": "It is not usually appropriate for junior grades to administer intrathecal chemotherapy as they may not have the necessary experience and expertise to carry out this procedure safely."
            },
            "type": "ListItem",
            "sequence_num": 243
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 24.3,
                "text": "National guidance makes provision for ST1 and ST2 grade staff to undertake intrathecal administration, by way of suitable training and their name being placed on the intrathecal register. Completion of a waiver is required and must be signed by all the following: site Medical Director, site Director of Nursing, Chief Pharmacist. The Chief Executive of the Trust, Chief Medical Officer and Chief Nursing Officer must be informed immediately."
            },
            "type": "ListItem",
            "sequence_num": 244
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 25.0,
                "text": "Record of Personnel Involvement"
            },
            "type": "ListItem",
            "sequence_num": 245
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 25.1,
                "text": "Once administration has been completed the Intrathecal Chemotherapy prescription chart must be returned to the oncology pharmacy for audit and recording of personnel involved in the procedure."
            },
            "type": "ListItem",
            "sequence_num": 246
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 25.2,
                "text": "When the relevant information has been recorded the Intrathecal Chemotherapy prescription chart must be returned to the patient's medical notes."
            },
            "type": "ListItem",
            "sequence_num": 247
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 26.0,
                "text": "Training Requirements"
            },
            "type": "ListItem",
            "sequence_num": 248
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 26.1,
                "text": "Specific induction and training is essential for medical, nursing and pharmacy staff involved in this procedure and a register of designated personnel has been established. This consists of personnel who have been trained and certified competent to do one or more of the following:"
            },
            "type": "ListItem",
            "sequence_num": 249
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Prescribe intrathecal chemotherapy;"
            },
            "type": "ListItem",
            "sequence_num": 250
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Verify intrathecal chemotherapy prescriptions;"
            },
            "type": "ListItem",
            "sequence_num": 251
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Dispense intrathecal chemotherapy drugs;"
            },
            "type": "ListItem",
            "sequence_num": 252
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Issuing intrathecal chemotherapy drugs from pharmacy;"
            },
            "type": "ListItem",
            "sequence_num": 253
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Checking intrathecal chemotherapy drugs prior to administration;"
            },
            "type": "ListItem",
            "sequence_num": 254
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Administering the intrathecal chemotherapy."
            },
            "type": "ListItem",
            "sequence_num": 255
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 26.2,
                "text": "This policy applies to appropriately trained medical, pharmacy and nursing staff who have been identified by medical, pharmacy or nursing leads to ensure that the number of intrathecal chemotherapy trained staff is sufficient for the needs of the service."
            },
            "type": "ListItem",
            "sequence_num": 256
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 26.3,
                "text": "All new clinical staff must be advised that they cannot prescribe, verify, dispense, issue, check or administer Intrathecal Chemotherapy until they have received appropriate training and their competency is agreed and documented."
            },
            "type": "ListItem",
            "sequence_num": 257
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 26.4,
                "text": "It is the responsibility of the designated lead, who maintains the register, through delegation to the local leads, to ensure that all staff who are new to the ward or department, attend a formal induction course appropriate to their needs with regard to prescribing, verification, dispensing, storage, issuing, checking and practical administration of Intrathecal chemotherapy."
            },
            "type": "ListItem",
            "sequence_num": 258
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 26.5,
                "text": "Induction must cover all potential clinical hazards associated with Intrathecal chemotherapy and the danger posed to patients if chemotherapy drugs are accidentally administered by the incorrect route."
            },
            "type": "ListItem",
            "sequence_num": 259
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 26.6,
                "text": "Staff will be asked to sign a register of attendance on the course and to confirm they have received copies of this document and the National Guidance on the Safe Administration of Intrathecal Chemotherapy."
            },
            "type": "ListItem",
            "sequence_num": 260
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 26.7,
                "text": "Only those staff members who have been trained and assessed as competent in a given task, according to the Trust's intrathecal chemotherapy training procedure, are eligible to be registered for that task."
            },
            "type": "ListItem",
            "sequence_num": 261
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 26.8,
                "text": "Staff who are not authorised to undertake any aspect of the Intrathecal Chemotherapy service, including locum/bank staff of any grade, must be made aware that they must not become involved in the procedure even if asked to do so."
            },
            "type": "ListItem",
            "sequence_num": 262
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 26.9,
                "text": "There will be a formal assessment to ensure all staff have read and understood the Trust's guidelines and protocols before they can practice their respective roles in Intrathecal Chemotherapy."
            },
            "type": "ListItem",
            "sequence_num": 263
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 26.1,
                "text": "All trainees will be provided with a certificate when they are competent to fulfil their designated roles. This will indicate the date at which update and re-assessment should take place. This date will be a maximum of 12 months from the date of assessment."
            },
            "type": "ListItem",
            "sequence_num": 264
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 26.11,
                "text": "The staff members name will be deleted from the register unless competence is reviewed and recertified within that time."
            },
            "type": "ListItem",
            "sequence_num": 265
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 26.12,
                "text": "Continuous Training"
            },
            "type": "ListItem",
            "sequence_num": 266
        },
        {
            "data": {
                "is_heading": 0,
                "text": "26.12.1 This is an essential part of the management of intrathecal chemotherapy. No deviation from this policy is allowed in the training and updating of individuals who are on the Intrathecal register."
            },
            "type": "ListItem",
            "sequence_num": 267
        },
        {
            "data": {
                "is_heading": 0,
                "text": "26.12.2 Reading and understanding of this policy is a mandatory pre-requisite to be considered eligible to be on the Intrathecal register and in mandatory annual reappraisal."
            },
            "type": "ListItem",
            "sequence_num": 268
        },
        {
            "data": {
                "is_heading": 0,
                "text": "26.12.3 The Local Leads/training leads are responsible for overall training and this should be reflected in his/her job description."
            },
            "type": "ListItem",
            "sequence_num": 269
        },
        {
            "data": {
                "is_heading": 0,
                "text": "26.12.4 Formal training and annual updating programmes on the practical administration of Intrathecal Chemotherapy must be a regular part of continuing professional education and training for all professional staff to enable them to remain on the Trust registers."
            },
            "type": "ListItem",
            "sequence_num": 270
        },
        {
            "data": {
                "is_heading": 0,
                "text": "26.12.5 The frequency of performing registered tasks should be reviewed as part of the annual training update and competency assessment."
            },
            "type": "ListItem",
            "sequence_num": 271
        },
        {
            "data": {
                "is_heading": 0,
                "text": "26.12.6 The \u2018Local leads' are responsible for ensuring medical, pharmacy and nursing staff complete an annual update to confirm their competence to prescribe and administer Intrathecal chemotherapy."
            },
            "type": "ListItem",
            "sequence_num": 272
        },
        {
            "data": {
                "is_heading": 0,
                "text": "26.12.7 The act of training may be delegated by the training lead to staff who meet the following criteria:"
            },
            "type": "ListItem",
            "sequence_num": 273
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Current job involves routinely working at a clinical level within the cancer specialty \u2013 this may be nursing, pharmacy or medical;"
            },
            "type": "ListItem",
            "sequence_num": 274
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Current job description specifically includes the requirement to undertake formal training of staff in clinical roles;"
            },
            "type": "ListItem",
            "sequence_num": 275
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Valid Intrathecal registration at the time of undertaking Intrathecal Training \u2013 i.e. their name appears on the Intrathecal Register within valid dates."
            },
            "type": "ListItem",
            "sequence_num": 276
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 26.13,
                "text": "Staff Moving From another Hospital"
            },
            "type": "ListItem",
            "sequence_num": 277
        },
        {
            "data": {
                "is_heading": 0,
                "text": "26.13.1 Staff coming from another hospital may bring with them their certification."
            },
            "type": "ListItem",
            "sequence_num": 278
        },
        {
            "data": {
                "is_heading": 0,
                "text": "26.13.2 However, in the absence of any common standards, they will still need to demonstrate their competence before being placed on the register of designated personnel."
            },
            "type": "ListItem",
            "sequence_num": 279
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 27.0,
                "text": "Monitoring and Audit"
            },
            "type": "ListItem",
            "sequence_num": 280
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 27.1,
                "text": "Outlined below is the Trust's process of monitoring compliance with, and the effectiveness of the document's main points."
            },
            "type": "ListItem",
            "sequence_num": 281
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 27.2,
                "text": "Compliance of this policy will be monitored by the MSE SACT Quality Group."
            },
            "type": "ListItem",
            "sequence_num": 282
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 27.3,
                "text": "Failure to follow this policy at any stage relating to intrathecal chemotherapy is classified as a hospital incident. All errors or near miss events relating to intrathecal chemotherapy must be brought to the attention of the Senior Medical, Nursing staff and Pharmacy Leads. For each incident monitored the appropriate action plans will be developed and put in place. All incidents are reported to the Trust SACT Quality Group and the Designated ITC Lead."
            },
            "type": "ListItem",
            "sequence_num": 283
        },
        {
            "type": "table",
            "sequence_num": 284,
            "data": {
                "num_rows": 3,
                "num_cols": 6,
                "table_items": [
                    {
                        "text": "Aspect of compliance or effectiveness being monitored"
                    },
                    {
                        "text": "Monitorin g Method"
                    },
                    {
                        "text": "Individual department responsibl e for the monitoring"
                    },
                    {
                        "text": "Frequency of the monitorin g activity"
                    },
                    {
                        "text": "Group / Committee / forum which will receive the findings/monitoring report"
                    },
                    {
                        "text": "Committee / individual responsible for ensuring the actions are completed"
                    },
                    {
                        "text": "Document Control and Training"
                    },
                    {
                        "text": "Cancer peer review"
                    },
                    {
                        "text": "Designated ITC Lead"
                    },
                    {
                        "text": "Quarterly"
                    },
                    {
                        "text": "SACT Quality Group"
                    },
                    {
                        "text": "Designated ITC Lead"
                    },
                    {
                        "text": "Incident management"
                    },
                    {
                        "text": "Incident reports"
                    },
                    {
                        "text": "Oncology and Pharmacy"
                    },
                    {
                        "text": "Monthly"
                    },
                    {
                        "text": "SACT Quality Group Site Medicines Optimisation and Safety Group"
                    },
                    {
                        "text": "Designated ITC Lead. Medicines Assurance Group"
                    }
                ]
            }
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 28.0,
                "text": "Approval and Implementation"
            },
            "type": "ListItem",
            "sequence_num": 285
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 28.1,
                "text": "All policies, procedures and guidelines will be approved by Medicines Assurance Group, which is the specialist group with the authority to approve local medication documents. These will then be forwarded to the Document control team for submission and ratification by the Joint Document Management Group."
            },
            "type": "ListItem",
            "sequence_num": 286
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 28.2,
                "text": "It is the author's responsibility to inform all prescribers, nursing and pharmacy of the approved policy documents when they are uploaded to the Trust's Intranets."
            },
            "type": "ListItem",
            "sequence_num": 287
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 29.0,
                "text": "Equality Impact Assessment"
            },
            "type": "ListItem",
            "sequence_num": 288
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 29.1,
                "text": "The Trust is committed to the provision of a service that is fair, accessible and meets the needs of all individuals."
            },
            "type": "ListItem",
            "sequence_num": 289
        },
        {
            "data": {
                "is_heading": 0,
                "text": "(Refer to appendix 1)"
            },
            "type": "ListItem",
            "sequence_num": 290
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 30.0,
                "text": "References"
            },
            "type": "ListItem",
            "sequence_num": 291
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Updated National Guidance on the safe administration of Intrathecal Chemotherapy, Dept of Health HSC 2008/001 11th August 2008."
            },
            "type": "ListItem",
            "sequence_num": 292
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Patient Safety Alert NHS/PSA/RE/2017/004, NHS Improvement, August 2017"
            },
            "type": "ListItem",
            "sequence_num": 293
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Management of IntraTHECAL Chemotherapy Policy / MSEPO-21088/1.0"
            },
            "type": "ListItem",
            "sequence_num": 294
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 25.0,
                "text": "Page  of"
            },
            "type": "ListItem",
            "sequence_num": 295
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Management of IntraTHECAL Chemotherapy Policy / MSEPO-21088/1.0"
            },
            "type": "ListItem",
            "sequence_num": 296
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Appendix1: Preliminary Equality Analysis"
            },
            "type": "ListItem",
            "sequence_num": 297
        },
        {
            "data": {
                "is_heading": 1,
                "text": "This assessment relates to Policy for the Management of Intrathecal Chemotherapy: (Please tick all that apply)"
            },
            "type": "ListItem",
            "sequence_num": 298
        },
        {
            "type": "table",
            "sequence_num": 299,
            "data": {
                "num_rows": 3,
                "num_cols": 3,
                "table_items": [
                    {
                        "text": "\u2610 A change in a service to patients"
                    },
                    {
                        "text": "\u2610 A change to an existing document"
                    },
                    {
                        "text": "\u2610 A change to the way staff work"
                    },
                    {
                        "text": "\u2612 A new document"
                    },
                    {
                        "text": "\u2610 Something else (please give details)"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 300,
            "data": {
                "num_rows": 7,
                "num_cols": 2,
                "table_items": [
                    {
                        "text": "Questions"
                    },
                    {
                        "text": "Answers"
                    },
                    {
                        "text": "1."
                    },
                    {
                        "text": "What are you proposing to change?"
                    },
                    {
                        "text": "Harmonisation for Trust-wide use"
                    },
                    {
                        "text": "2."
                    },
                    {
                        "text": "Why are you making this change? (What will the change achieve?)"
                    },
                    {
                        "text": "Harmonised documentation"
                    },
                    {
                        "text": "3."
                    },
                    {
                        "text": "Who benefits from this change and how?"
                    },
                    {
                        "text": "Staff and Patients have consistent processes applied for high risk medicine"
                    },
                    {
                        "text": "4."
                    },
                    {
                        "text": "Is anyone likely to suffer any negative impact as a result of this change? If no, please record reasons here and sign and date this assessment. If yes, please complete a full EIA."
                    },
                    {
                        "text": "No \u2013 in line with national best practice and mandatory compliance"
                    },
                    {
                        "text": "5."
                    },
                    {
                        "text": "a) Will you be undertaking any consultation as part of this change?"
                    },
                    {
                        "text": "Yes"
                    },
                    {
                        "text": "b) If so, with whom?"
                    },
                    {
                        "text": "Refer to pages 1 & 2"
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 301,
            "data": {
                "num_rows": 2,
                "num_cols": 3,
                "table_items": [
                    {
                        "text": "Preliminary analysis completed by:"
                    },
                    {
                        "text": "Name"
                    },
                    {
                        "text": "Simon Worrall"
                    },
                    {
                        "text": "Job Title"
                    },
                    {
                        "text": "Deputy Chief Pharmacist"
                    },
                    {
                        "text": "11 May 2021"
                    }
                ]
            }
        },
        {
            "data": {
                "is_heading": 1,
                "text": "If you have identified any negative impact in the preliminary analysis above, please request and complete the full Equality Impact Assessment (EIA) from Document Control."
            },
            "type": "ListItem",
            "sequence_num": 302
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 23.0,
                "text": "Page  of"
            },
            "type": "ListItem",
            "sequence_num": 303
        }
    ]
}